REGENTIS BIOMATERIALS
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration. The company’s core technology is a iodegradable hydrogel called Gelrin™. It is based on polyethylene glycol diacrylate and denatured fibrinogen originally developed at the Technion University by Dr. Dror Seliktar. The Gelrin hydrogel platform combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications and has undergone extensive preclinical and safety testing over the last few years. The company’s flagship product, GelrinC™,designed for the treatment of articular cartilage lesions, is currently in clinical trials.
REGENTIS BIOMATERIALS
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2004-01-01
Address:
Or Akiva, Hefa, Israel
Country:
Israel
Website Url:
http://www.regentis.co.il
Total Employee:
11+
Status:
Active
Contact:
97248546644
Email Addresses:
[email protected]
Total Funding:
36.08 M USD
Technology used in webpage:
Domain Not Resolving ASP.NET IIS IIS 8 Parallels Plesk Panel Plesk Shockwave Flash Embed Classic ASP IIS 6 Microsoft Office Web Server
Similar Organizations
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Regentis Biomaterials
Medica Venture Partners
Medica Venture Partners investment in Series D - Regentis Biomaterials
T3
T3 investment in Series D - Regentis Biomaterials
Haisco
Haisco investment in Series D - Regentis Biomaterials
SCP Vitalife Partners
SCP Vitalife Partners investment in Series D - Regentis Biomaterials
Generali Investments Europe
Generali Investments Europe investment in Series D - Regentis Biomaterials
SCP Vitalife Partners
SCP Vitalife Partners investment in Series C - Regentis Biomaterials
Medica Venture Partners
Medica Venture Partners investment in Series C - Regentis Biomaterials
DSM Venturing
DSM Venturing investment in Series C - Regentis Biomaterials
ProSeed Venture Capital Fund
ProSeed Venture Capital Fund investment in Series B - Regentis Biomaterials
Official Site Inspections
http://www.regentis.co.il
- Host name: 87.140.167.72.host.secureserver.net
- IP address: 72.167.140.87
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Regentis Biomaterials"
Regentis Biomaterials
Regentis Biomaterials is a tissue repair company focused on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue. The company’s current efforts …See details»
Company Profile - Regentis Biomaterials
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore the health and enhance quality of life of patients.See details»
Regentis Biomaterials - Crunchbase Company Profile
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration. The company’s …See details»
Regentis Biomaterials Company Profile 2024: Valuation, …
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality …See details»
Management Team - Regentis Biomaterials
Dr. Eli Hazum has served as Regentis’ Chief Executive Officer since October 2021. He has been a partner and Chief Scientific Officer of Medica Venture Partners since 1995.See details»
Regentis Biomaterials - VentureRadar
Website: http://www.regentis.co.il. Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration.See details»
REGENTIS BIOMATERIALS LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for REGENTIS BIOMATERIALS LTD of OR AKIVA, Sharon Area. Get the latest business insights from Dun & …See details»
Regentis Biomaterials - LinkedIn
Regentis Biomaterials | 370 followers on LinkedIn. With offices in Princeton, New Jersey, and Or Akiva, Israel, Regentis Biomaterials is a privately held company focused on developing and...See details»
Regentis Biomaterials Ltd. - Company Profile & Staff Directory
With offices in Princeton, New Jersey, and Or Akiva, Israel, Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue …See details»
Investors - Regentis Biomaterials
Allegro S.à r.l. acting for and on behalf of the Crossroad Fund. Haisco Pharmaceutical Group Co. Ltd. Technion R&D Foundation (TRDF) Technion Investment Opportunities Fund L.P.See details»
Regentis Biomaterials - Craft
Regentis Biomaterials is a tissue repair company. It specializes in developing and commercializing hydrogel platform for the repair of damaged tissue. Regentis Biomaterials has …See details»
Regentis Biomaterials Ltd to Become Publicly Listed on Nasdaq via ...
May 3, 2023 · Regentis Biomaterials Ltd (“Regentis”) is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore the health and enhance …See details»
Israeli Start-up That Treats Knee Cartilage Injuries Raises $15M for …
Feb 10, 2016 · Regentis Biomaterials is a privately held company developing biodegradable hydrogels for the regeneration of damaged or diseased tissue. The company's first product is …See details»
Regentis Biomaterials Expands Clinical Study of GelrinC for …
Apr 10, 2013 · Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced today that it has expanded the …See details»
Contact Us - Regentis Biomaterials
Regentis Biomaterials Ltd. 60, Medinat Hyahudim Entrance C Herzlia Pituach, Israel 4676652. For general inquiries: Dr. Ehud Geller +972-9-960-1917 Email: [email protected]See details»
Regentis Co-Founder Wins Prize for Regenerative Medicine Research
Dec 5, 2017 · With offices in Or Akiva, Israel and Princeton, NJ, Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for …See details»
Regentis Biomaterials Receives European CE Mark Approval for
Aug 28, 2017 · Regentis Biomaterials Ltd. [http://www.regentis.co.il ], a privately held company developing proprietary hydrogels for tissue regeneration, announced today it has received …See details»
Board of Directors - Regentis Biomaterials
Mr. Jeff Dykan has served on the Regentis Board of Directors since 2005. He was appointed by Regentis’ shareholder SCP Vitalife.See details»
Gelrin Technology and Status - Regentis Biomaterials
Gelrin is a patented hydrogel platform originally developed at the Technion – Israel Institute of Technology by Prof. Dror Seliktar. Itis a family of hydrogels that derive their unique physical …See details»
Israeli Start-up That Treats Knee Cartilage Injuries Raises
Feb 10, 2016 · Regentis Biomaterials is a privately held company developing biodegradable hydrogels for the regeneration of damaged or diseased tissue. The company's first product is …See details»